Article Sidebar
Views pdf: 165
A VERIFICATION METHOD IN NEWBORNS SCREENING OF METABOLIC DISORDERS BY THE NEOBASE 2 MSMS KIT USING XEVO TQD
Main Article Content
Abstract
VerifiCation is required before implemeting a new test method in use. Linearity, preCision, aCCuraCy
eValutions were Carried out to Verify the performanCe of the Waters XEVO TQD MSMS system with the Neobase non-deriVatized MSMS Perkin Elmer kit for deteCting amino aCids and aCylCarnitine in newborns with metaboliC disorders. ACCeptanCe Criteria applied aCCording to CLSI - NBS04 2017 guidelines giVes the following results: Correlation CoeffiCient (r) ≥ 0,99 indiCates good linearity, within-run precisiOn CV ≤ 25%, between-run precisiOn CV ≤ 35%, recOvery is 40-140%. The results show that the linear range has the Correlation CoeffiCient from 0,9947 to 0,9998, the within-run preCision ranges from 2,83 – 10,12%, the between-run preCision ranges from 5,56 – 17,02%, reCoVery of 70,77 – 101,48% of metabolites Confirmed to be in aCCordanCe with the manufaCturer's Claim. Testing for Congenital metaboliC disorders by MSMS method is aCCurate and reliable in the aCtual Conditions of the testing Center - Gentis GenetiC SerViCes Joint StoCk Company, used in CliniCal praCtiCe to sCreen some Congenital metaboliC disorders
Article Details
Keywords
NBS04, XeVo TQD, Neobase2
References
2. Pourfarzam M, Zadhoush F. Newborn SCreening for inherited metaboliC disorders; news and Views. J Res Med SCi. 2013;18(9):801-808.
3. Banta-Wright SA, Steiner RD. Tandem mass speCtrometry in newborn sCreening: a primer for neonatal and perinatal nurses. J Perinat Neonatal Nurs. 2004;18(1):41-58;
4. Clinical Laboratory Standard Institute. Measurement ProCedure Comparison and Bias Estimation Using Patient Samples; ApproVed Guideline—Third Edition (2013). CLSI doCument EP09, 33(11)
5. Lee B, Heo WY, Kim JA, et al. ComprehensiVe EValuation of the NeoBase 2 Non-deriVatized MSMS Assay and Exploration of Analytes With SignifiCantly Different ConCentrations Between Term and Preterm Neonates. Ann Lab Med. 2023;43(2):153-166.
6. Clinical Laboratory Standard Institute (2017). Newborn SCreening by Tandem Mass SpeCtrometry; ApproVed Guideline. CLSI doCument NBS04, 37(9)
7. Zheng Y, Chen Y, Qiu X, et al. A VerifiCation of the appliCation of the non-deriVatized mass speCtrometry method in newborns sCreening of metaboliC disorders. MediCine (Baltimore). 2019;98(19):e15500.